NCT07336290Enrolling by invitation
One-stop Evaluation of Hypertrophic Cardiomyopathy in Cardiac Magnetic Resonance
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
This is a multi-center, observational study aiming to establish a precision diagnosis scheme and multi-dimensional risk prediction models for Hypertrophic Cardiomyopathy (HCM). The study plans to enroll 10000 adult HCM patients. It will integrate genetic testing, advanced cardiac imaging (echocardiography and cardiac magnetic resonance), and biomarker analysis to develop early diagnosis, differential diagnosis, and new risk prediction models for sudden cardiac death (SCD) and heart failure in HCM patients. Participants will undergo baseline assessments and be followed up every six months for up to 3 years to track clinical outcomes. This study is non-interventional and does not involve any investigational drugs or devices.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 2 Jan 2026
- Start date
- 1 Jan 2010
- Primary completion date
- 30 Jul 2028
- Lead sponsor
- Minjie Lu
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT07336290
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Jan 2010 to the primary completion date, 30 Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Presence of any contraindication to CMR examination.
- Unwillingness to participate in the study or to provide informed consent.
Who the study is looking for
- A maximal left ventricular wall thickness of ≥ 12 mm in any segment at end-diastole, as measured by echocardiography or Cardiac Magnetic Resonance (CMR)
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.